版权说明 操作指南
首页 > 成果 > 详情

Targeting ENPP1 for cancer immunotherapy: Killing two birds with one stone

认领
导出
Link by DOI
反馈
分享
QQ微信 微博
成果类型:
期刊论文
作者:
Huang, Ruilei;Ning, Qian;Zhao, Jihui;Zhao, Xuhong;Zeng, Luting;...
通讯作者:
Tang, SS
作者机构:
[Zhao, Jihui; Tang, SS; Tang, Shengsong; Zeng, Luting; Zhao, Xuhong; Ning, Qian; Huang, Ruilei; Yi, Yi] Hunan Univ Med, Sch Pharmaceut Sci, Hunan Prov Key Lab Antibody Based Drug & Intellig, Huaihua 418000, Peoples R China.
[Tang, Shengsong; Ning, Qian] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Peoples R China.
[Tang, Shengsong] Univ South China, Hunan Prov Key Lab Tumor Microenvironm Respons Dru, Hengyang 421001, Peoples R China.
[Tang, Shengsong] Univ South China, Inst Pharm & Pharmacol, Hengyang 421001, Peoples R China.
通讯机构:
[Tang, SS ] H
Hunan Univ Med, Sch Pharmaceut Sci, Hunan Prov Key Lab Antibody Based Drug & Intellig, Huaihua 418000, Peoples R China.
语种:
英文
关键词:
Adenosine;ENPP1;ENPP1 inhibitors;Immunotherapy;cGAMP;cGAS-STING signaling pathway
期刊:
Biochemical Pharmacology
ISSN:
0006-2952
年:
2024
卷:
220
页码:
116006
基金类别:
Hunan Provincial Science and Technology Plan Key Projects of China [2017SK2183]; Scientific Research Project of Hunan Provincial Health Commission [202113022028]; Scientific Research Fund of Hunan Provincial Education Department [21C1379, 22B1039]; Hunan Provincial Natural Science Foundation of China [2023JJ50444, 2023JJ50076]
机构署名:
本校为其他机构
院系归属:
药学与生物科学学院
摘要:
Cancer immunotherapy, particularly with immune checkpoint inhibitors, has revolutionized the paradigm of cancer treatment. Nevertheless, the efficacy of cancer immunotherapy remains limited in most clinical settings due to the lack of a preexisting antitumor T-cell response in tumors. Therefore, the clinical outcomes of cancer immunotherapy must be improved crucially. With increased awareness of the importance of the innate immune response in the recruitment of T cells, as well as the onset and maintenance of the T cell response, great interest has been shown in activating the cGAS-STING signa...

反馈

验证码:
看不清楚,换一个
确定
取消

成果认领

标题:
用户 作者 通讯作者
请选择
请选择
确定
取消

提示

该栏目需要登录且有访问权限才可以访问

如果您有访问权限,请直接 登录访问

如果您没有访问权限,请联系管理员申请开通

管理员联系邮箱:yun@hnwdkj.com